Top

Published in:

01-12-2009 | Original Article

Vitamin D₃ induces expression of human cathelicidin antimicrobial peptide 18 in newborns

Authors: Yuka Misawa, Atsushi Baba, Susumu Ito, Miyuki Tanaka, Masaaki Shiohara

Published in: International Journal of Hematology | Issue 5/2009

Abstract

Bactericidal activities of neutrophils occur by two distinctive mechanisms that are oxygen-dependent and -independent. Human cathelicidin antimicrobial peptide 18 (hCAP18), also known as LL-37/FALL-39, is a neutrophil-specific granule protein. We compared the content of hCAP18 and neutrophil gelatinase-associated lipocalin (NGAL), another neutrophil-specific granule protein, in neutrophils of both neonates and adults by flow cytometry. The percentage as well as fluorescence intensity ratio of hCAP18 and NGAL expression in neonate neutrophils were significantly lower than in adults. Expression of hCAP18 in monocytes, however, was not significantly different between neonates and adults. Both hCAP18 and NGAL expression increased in an age-dependent fashion. Plasma concentration of these peptides measured by enzyme-linked immunosorbent assay was not significantly different between neonates and adults. Oral intake of 1α hydroxy vitamin D₃ (1α(OH)D₃) in rickets patients for 4 weeks significantly increased hCAP18 expression in neutrophils compared to age-matched healthy controls without 1α(OH)D₃, indicating the potential of vitamin D₃ as a regulator of the innate immune response of neonates.

Polin RA, Parravicini E, Regan JA, Taeusch HW. Bacterial sepsis and meningitis. In: Taeusch HW, Ballard RA, Gleason CA, editors. Avery’s diseases of the newborn. 8th ed. Philadelphia: Elsevier Saunders; 2005. p. 551–77.CrossRef

Stoll BJ. Infections of the neonatal infant. In: Kliegman RM, Jenson HB, Behrman RE, Stanton BF, editors. Textbook of pediatrics. 18th ed. Philadelphia: Elsevier Saunders; 2007. p. 794–811.

Takimoto H, Yokoyama T, Yoshiike N, Fukuoka H. Increase in low-birth-weight infants in Japan and associated risk factors, 1980–2000. J Obstet Gynaecol Res. 2005;31:314–22.CrossRefPubMed

Baltimore RS. Perinatal bacterial and fungal infections. In: Jenson HB, Baltimore RS, editors. Pediatric infectious diseases. 2nd ed. Philadelphia: W.B. Saunders; 2002. p. 1119–34.

Gaynes RP, Edwards JR, Jarvis WR, Culver DH, Tolson JS, Martone WJ. Nosocomial infections among neonates in high-risk nurseries in the United States. National nosocomial infections surveillance system. Pediatrics. 1996;98:357–61.PubMed

Lewis DB, Wilson CB. Developmental immunology and role of host defences in neonatal susceptibility to infection. In: Remington JS, Klein JO, editors. Infectious diseases of the fetus and newborn infant. 4th ed. Philadelphia: Saunders; 2000. p. 20–99.

Borregaard N, Cowland JB. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood. 1997;89:3503–21.PubMed

Gullberg U, Andersson E, Garwicz D, Lindmark A, Olsson I. Biosynthesis, processing and sorting of neutrophil proteins: insight into neutrophil granule development. Eur J Haematol. 1997;58:137–53.CrossRefPubMed

Borregaard N, Theilgaard-Monch K, Sorensen OE, Cowland JB. Regulation of human neutrophil granule protein expression. Curr Opin Hematol. 2001;8:23–7.CrossRefPubMed

10.

Larrick JW, Hirata M, Balint RF, Lee J, Zhong J, Wright SC. Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect Immun. 1995;63:1291–7.PubMedPubMedCentral

11.

Agerberth B, Gunne H, Odeberg J, Kogner P, Boman HG, Gudmundsson GH. FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc Natl Acad Sci USA. 1995;92:195–9.CrossRefPubMedPubMedCentral

12.

Sorensen OE, Follin P, Johnsen AH, Calafat J, Tjabringa GS, Hiemstra PS, et al. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood. 2001;97:3951–9.CrossRefPubMed

13.

Durr UH, Sudheendra US, Ramamoorthy A. LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim Biophys Acta. 2006;1758:1408–25.CrossRefPubMed

14.

Zanetti M, Gennaro R, Romeo D. Cathelicidins: a novel family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett. 1995;374:1–5.CrossRefPubMed

15.

Sorensen O, Arnljots K, Cowland JB, Bainton DF, Borregaard N. The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils. Blood. 1997;90:2796–803.PubMed

16.

Frohm-Nilsson M, Sandstedt B, Sorensen O, Weber G, Borregaard N, Stahle-Backdahl M. The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infect Immun. 1999;67:2561–6.PubMedPubMedCentral

17.

Malm J, Sorensen O, Persson T, Frohm-Nilsson M, Johansson B, Bjartell A, et al. The human cationic antimicrobial protein (hCAP-18) is expressed in the epithelium of human epididymis, is present in seminal plasma at high concentrations, and is attached to spermatozoa. Infect Immun. 2000;68:4297–302.CrossRefPubMedPubMedCentral

18.

Bals R, Wang X, Zasloff M, Wilson JM. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of human lung where it has broad antimicrobial activity at the airway surface. Proc Natl Acad Sci USA. 1998;95:9541–6.CrossRefPubMedPubMedCentral

19.

Frohm M, Agerberth B, Ahangari G, Stahle-Backdahl M, Liden S, Wigzell H, et al. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem. 1997;272:15258–63.CrossRefPubMed

20.

Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria ? Nat Rev Microbiol. 2005;3:238–50.CrossRefPubMed

21.

Kjeldsen L, Bainton DF, Sengelov H, Borregaard N. Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils. Blood. 1994;83:799–807.PubMed

22.

Goetz DH, Holmes MA, Borregaard N, Bluhm ME, Raymond KN, Strong RK. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell. 2002;10:1033–43.CrossRefPubMed

23.

Gordon YJ, Huang LC, Romanowski EG, Yates KA, Proske RJ, Dermott AM. Human cathelicidin (LL-37), a multifunctional peptide, is expressed by ocular surface epithelia and has potent antibacterial and antiviral activity. Curr Eye Res. 2005;30:385–94.CrossRefPubMedPubMedCentral

24.

Bergman P, Walter-Jallow L, Broliden K, Agerberth B, Soderlund J. The antimicrobial peptide LL-37 inhibits HIV-1 replication. Curr HIV Res. 2007;5:410–5.CrossRefPubMed

25.

Yang D, Chen Q, Schmidt AP, Anderson GM, Wang JM, Wooters J, et al. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med. 2000;192:1069–74.CrossRefPubMedPubMedCentral

26.

Niyonsaba F, Iwabuchi K, Someya A, Hirata M, Matsuda H, Ogawa H, et al. A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis. Immunology. 2002;106:20–6.CrossRefPubMedPubMedCentral

27.

Davidson DJ, Currie AJ, Reid GS, Bowdish DM, MacDonald KL, Ma RC, et al. The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J Immunol. 2004;172:1146–56.CrossRefPubMed

28.

Nagaoka I, Tamura H, Hirata M. An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7. J Immunol. 2006;176:3044–52.CrossRefPubMed

29.

Lekstrom-Himes JA, Dorman SE, Kopar P, Holland SM, Gallin JI. Neutrophil-specific granule deficiency results from a novel mutation with loss of function of the transcription factor CCAAT/enhancer binding protein ε. J Exp Med. 1999;189:1847–52.CrossRefPubMedPubMedCentral

30.

Gombart AF, Shiohara M, Kwok SH, Agematsu K, Komiyama A, Koeffler HP. Neutrophil-specific granule deficiency: homozygous recessive inheritance of a frameshift mutation in the gene encoding transcription factor CCAAT/enhancer binding protein-ε. Blood. 2001;97:2561–7.CrossRefPubMed

31.

Klein RB, Fischer TJ, Gard SE, Biberstein M, Rich KC, Stiehm ER. Decreased mononuclear and polymorphonuclear chemotaxis in human newborns, infants, and young children. Pediatrics. 1977;60:467–72.PubMed

32.

Krause PJ, Herson VC, Boutin-Lebowitz J, Eisenfeld L, Block C, Lobello T, et al. Polymorphonuclear leukocyte adherence and chemotaxis in stressed and healthy neonates. Pediatr Res. 1986;20:296–300.CrossRefPubMed

33.

Ambruso DR, Stork LC, Gibson BE, Thurman GW. Increased activity of the respiratory burst in cord blood neutrophils: kinetics of the NADPH oxidase enzyme system in subcellular fractions. Pediatr Res. 1987;21:205–10.CrossRefPubMed

34.

Tanaka M, Gombart AF, Koeffler HP, Shiohara M. Expression of bactericidal/permeability-increasing protein requires C/EBPε. Int J Hematol. 2007;85:304–11.CrossRefPubMed

35.

Shiohara M, Taniguchi S, Masumoto J, Yasui K, Koike K, Komiyama A, et al. ASC, which is composed of a PYD and a CARD, is up-regulated by inflammation and apoptosis in human neutrophils. Biochem Biophys Res Commun. 2002;293:1314–8.CrossRefPubMed

36.

Gessner JE, Grussenmeyer T, Kolanus W, Schmidt RE. The human low affinity immunoglobulin G Fc receptor III-A and III-B genes. Molecular characterization of the promoter regions. J Biol Chem. 1995;270:1350–61.CrossRefPubMed

37.

Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem. 1993;268:10425–32.PubMed

38.

Agerberth B, Charo J, Werr J, Olsson B, Idali F, Lindbom L, et al. The human antimicrobial and chemotactic peptides LL-37 and alfa-defensins are expressed by specific lymphocyte and monocyte populations. Blood. 2000;96:3086–93.PubMed

39.

Sorensen O, Bratt T, Johnsen AH, Madsen MT, Borregaard N. The human antibacterial cathelicidin, hCAP-18, is bound to lipoproteins in plasma. J Biol Chem. 1999;274:22445–51.CrossRefPubMed

40.

Nielsen BS, Borregaard N, Bundgaard JR, Timshel S, Sehested M, Kjeldsen L. Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. Gut. 1996;38:414–20.CrossRefPubMedPubMedCentral

41.

Woo JS, Kim KM, Kang JS, Zodpe P, Chae SW, Hwang SJ, et al. Expression of neutrophil gelatinase-associated lipocalin in human salivary glands. Ann Otol Rhinol Laryngol. 2007;116:599–603.CrossRefPubMed

42.

Gombart AF, Borregaard N, Koeffler HP. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J. 2005;19:1067–77.CrossRefPubMed

43.

Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311:1770–3.CrossRefPubMed

44.

Gombart AF, O’Kelly J, Saito T, Koeffler HP. Regulation of the CAMP gene by 1, 25(OH)2D3 in various tissues. J Steroid Biochem Mol Biol. 2007;103:552–7.CrossRefPubMed

45.

Liu PT, Stenger S, Tang DH, Modlin RL. Vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol. 2007;179:2060–3.CrossRefPubMed

46.

Ambruso DR, Bentwood B, Henson PM, Jr. Johnston RB. Oxidative metabolism of cord blood neutrophils: relationship to content and degranulation of cytoplasmic granules. Pediatr Res. 1984;18:1148–53.CrossRefPubMed

47.

Levy O, Martin S, Eichenwald E, Ganz T, Valore E, Carroll SF, et al. Impaired innate immunity in the newborn: newborn neutrophils are deficient in bactericidal/permeability-increasing protein. Pediatrics. 1999;104:1327–33.CrossRefPubMed

48.

Bowdish DM, Davidson DJ, Hancock RE. A re-evaluation of the role of host defence peptides in mammalian immunity. Curr Protein Pept Sci. 2005;6:35–51.CrossRefPubMed

49.

Gombart AF, Kwok SH, Anderson KL, Yamaguchi Y, Torbett BE, Koeffler HP. Regulation of neutrophil and eosinophil secondary granule gene expression by transcription factors C/EBPε and PU.1. Blood. 2003;101:3265–73.CrossRefPubMed

50.

Khanna-Gupta A, Zibello T, Sun H, Gaines P, Berliner N. Chromatin immunoprecipitation (ChIP) studies indicate a role for CCAAT enhancer binding proteins alpha and epsilon (C/EBPα and C/EBPε) and CDP/cut in myeloid maturation-induced lactoferrin gene expression. Bood. 2003;101:3460–8.

51.

Greenbaum LA. Rickets and hypervitaminosis. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF, editors. Textbook of pediatrics. 18th ed. ed. Philadelphia: Elsevier Saundars; 2007. p. 253–63.

52.

Chuang YY, Huang YC, Lee CY, Lin TY, Lien R, Chou YH. Methicillin-resistant Staphylococcus aureus bacteraemia in neonatal intensive care units: an analysis of 90 episodes. Acta Paediatr. 2004;93:786–90.CrossRefPubMed

53.

Crivaro V, Bagattini M, Salza MF, Raimondi F, Rossano F, Triassi M, et al. Risk factors for extended-spectrum beta-lactamase-producing Serratia marcescens and Klebsiella pneumoniae acquisition in a neonatal intensive care unit. J Hosp Infect. 2007;67:135–41.CrossRefPubMed

54.

Hancock RE, Patrzykat A. Clinical development of cationic antimicrobial peptides: from natural to novel antibiotics. Curr Drug Targets Infect Disord. 2002;2:79–83.CrossRefPubMed

55.

Zasloff M. Antimicrobial peptides in health and disease. N Engl J Med. 2002;347:1199–200.CrossRefPubMed

Title: Vitamin D3 induces expression of human cathelicidin antimicrobial peptide 18 in newborns
Authors: Yuka Misawa
Atsushi Baba
Susumu Ito
Miyuki Tanaka
Masaaki Shiohara
Publication date: 01-12-2009
Publisher: Springer Japan
Published in: International Journal of Hematology / Issue 5/2009
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI: https://doi.org/10.1007/s12185-009-0452-9

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2009

ATL-like marked atypical lymphocytosis associated with drug-induced hypersensitivity syndrome and human herpesvirus-6 reactivation

Flow cytometric analysis of skin blister fluid induced by mosquito bites in a patient with chronic active Epstein–Barr virus infection

Extranodal NK/T cell lymphoma, nasal type, of the small intestine diagnosed by double-balloon endoscopy

The presence of mature granulocytes/monocytes derived from leukemic cells in MLL-associated leukemia

Treosulfan-based conditioning regimen in a second matched unrelated peripheral blood stem cell transplantation for a pediatric patient with CGD and invasive aspergillosis, who experienced initial graft failure after RIC

Immunosuppressive treatment in patient with pure red cell aplasia associated with chronic myelomonocytic leukemia: harm or benefit?

Keynote webinar | Spotlight on antibody–drug conjugates in cancer